Pharming Group N.V. (PHGUF)
OTCMKTS · Delayed Price · Currency is USD
1.300
+0.140 (12.07%)
At close: Aug 22, 2025
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $975.57 million as of September 10, 2025. Its market cap has increased by 84.17% in one year.
Market Cap
975.57M
Enterprise Value
977.88M
Revenue
339.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.30
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from 128.85M to 975.57M, an increase of 657.11%. That is a compound annual growth rate of 8.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 975.57M | 50.17% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | 992.79M | -10.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 742.62M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 372.66M |
| American Oncology Network | 353.52M |